MXPA05013625A - Combinaciones de agentes vasoprotectores y formulaciones que contienen los mismos. - Google Patents

Combinaciones de agentes vasoprotectores y formulaciones que contienen los mismos.

Info

Publication number
MXPA05013625A
MXPA05013625A MXPA05013625A MXPA05013625A MXPA05013625A MX PA05013625 A MXPA05013625 A MX PA05013625A MX PA05013625 A MXPA05013625 A MX PA05013625A MX PA05013625 A MXPA05013625 A MX PA05013625A MX PA05013625 A MXPA05013625 A MX PA05013625A
Authority
MX
Mexico
Prior art keywords
combinations
formulations containing
vasoprotective agents
vasoprotective
agents
Prior art date
Application number
MXPA05013625A
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of MXPA05013625A publication Critical patent/MXPA05013625A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Combinaciones de agentes vascoprotectores utiles para la prevencion y el tratamiento de danos vasculares inducidos por un exceso de lipidos en el plasma, que comprenden oligomeros de policosanoles, tocotrienoles y/o licopeno, y aceite vegetal rico en acidos grasos insaturados.
MXPA05013625A 2003-06-27 2004-06-17 Combinaciones de agentes vasoprotectores y formulaciones que contienen los mismos. MXPA05013625A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001313A ITMI20031313A1 (it) 2003-06-27 2003-06-27 Associazioni di agenti vasoprotettori e formulazioni che li contengono.
PCT/EP2004/006507 WO2005000041A1 (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them

Publications (1)

Publication Number Publication Date
MXPA05013625A true MXPA05013625A (es) 2006-02-24

Family

ID=30131309

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05013625A MXPA05013625A (es) 2003-06-27 2004-06-17 Combinaciones de agentes vasoprotectores y formulaciones que contienen los mismos.

Country Status (22)

Country Link
US (3) US20090036520A1 (es)
EP (1) EP1638417B1 (es)
JP (1) JP4960087B2 (es)
KR (1) KR101165934B1 (es)
CN (1) CN100475061C (es)
AU (1) AU2004251009B2 (es)
BR (1) BRPI0411811B1 (es)
CA (1) CA2530660C (es)
DK (1) DK1638417T3 (es)
ES (1) ES2704633T3 (es)
HK (1) HK1090519A1 (es)
HU (1) HUE042048T2 (es)
IT (1) ITMI20031313A1 (es)
MX (1) MXPA05013625A (es)
NO (1) NO330523B1 (es)
NZ (1) NZ544399A (es)
PL (1) PL1638417T3 (es)
PT (1) PT1638417T (es)
RU (2) RU2361430C2 (es)
SI (1) SI1638417T1 (es)
TR (1) TR201900241T4 (es)
WO (1) WO2005000041A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017153B2 (en) 2006-02-07 2011-09-13 U.S. Nutraceuticals, LLC Dietary supplement composition for blood lipid health
US8202541B2 (en) 2006-02-07 2012-06-19 U.S. Nutraceuticals, LLC Dietary supplement composition for blood lipid health
JP4469406B1 (ja) * 2009-06-30 2010-05-26 株式会社ファンケル 血中コレステロール低下剤
JP4469407B1 (ja) * 2009-06-30 2010-05-26 株式会社ファンケル 血中中性脂肪低下剤
KR101294970B1 (ko) * 2011-06-30 2013-08-09 고려대학교 산학협력단 폴리코사놀 에스터, 이의 제조 방법 및 이를 포함하는 첨가제
CN105188687B (zh) * 2013-03-15 2018-05-01 奈米瑞斯公司 Metadichol*液体和凝胶纳米颗粒制剂
IT201900020808A1 (it) * 2019-11-11 2021-05-11 Neilos S R L Composizione per la riduzione del rischio cardiovascolare

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
JP3142245B2 (ja) * 1996-06-28 2001-03-07 株式会社資生堂 皮膚外用剤
IT1283143B1 (it) * 1996-07-12 1998-04-07 Indena Spa Metodo di estrazione del licopene ed estratti che lo contengono
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
AU9209898A (en) * 1997-09-02 1999-03-22 Ricex Company, Inc., The A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
IT1296920B1 (it) * 1997-12-04 1999-08-03 Indena Spa Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
KR20000019717A (ko) * 1998-09-15 2000-04-15 박호군 루틴 및 쿼세틴을 포함하는 고지혈증, 동맥경화증 및 간 질환의예방 및 치료용 조성물
FR2792831B1 (fr) * 1999-04-28 2001-08-03 Bionatec Sarl Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier
KR100319397B1 (ko) 1999-07-12 2002-01-05 남 승 우 천연식물소재 추출물을 이용한 항혈전 및 고지혈증 억제 조성물
US6667064B2 (en) * 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
US20020120001A1 (en) * 2000-10-13 2002-08-29 Ashni Naturaceuticals, Inc. Compositions containing tryptamines, cartenoids and tocotrienols and having synergistic antioxidant effect
IT1320180B1 (it) * 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e

Also Published As

Publication number Publication date
US8206759B2 (en) 2012-06-26
NZ544399A (en) 2009-04-30
ES2704633T3 (es) 2019-03-19
KR101165934B1 (ko) 2012-07-19
TR201900241T4 (tr) 2019-02-21
AU2004251009A1 (en) 2005-01-06
EP1638417B1 (en) 2018-10-10
BRPI0411811B1 (pt) 2018-05-29
ITMI20031313A1 (it) 2004-12-28
HK1090519A1 (en) 2006-12-29
DK1638417T3 (en) 2019-01-28
US20110142967A1 (en) 2011-06-16
US20100160427A1 (en) 2010-06-24
RU2361430C2 (ru) 2009-07-20
HUE042048T2 (hu) 2019-06-28
AU2004251009B2 (en) 2010-06-17
SI1638417T1 (sl) 2019-02-28
RU2489907C2 (ru) 2013-08-20
RU2009109089A (ru) 2010-09-20
CN100475061C (zh) 2009-04-08
US20090036520A1 (en) 2009-02-05
KR20060072098A (ko) 2006-06-27
BRPI0411811A (pt) 2006-08-08
NO330523B1 (no) 2011-05-09
NO20056162L (no) 2005-12-23
RU2005140574A (ru) 2006-05-10
ITMI20031313A0 (it) 2003-06-27
EP1638417A1 (en) 2006-03-29
PL1638417T3 (pl) 2019-03-29
CN1812729A (zh) 2006-08-02
JP4960087B2 (ja) 2012-06-27
PT1638417T (pt) 2019-01-17
CA2530660A1 (en) 2005-01-06
CA2530660C (en) 2013-08-20
JP2007519603A (ja) 2007-07-19
WO2005000041A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
MX2008000915A (es) Tratamiento con inhibidores de absorcion de colesterol basados en azetidinona y acidos grasos omega-3 y un producto de combinacion de los mismos.
BRPI0513602A (pt) composições congeladas, composições para a obtenção de um produto de alimento congelado e usos de hidrofobina
WO2002077199A3 (en) Methods and products related to fgf dimerization
AR028512A1 (es) Composiciones antimicrobianas acidas para el tratamiento de alimentos y superficies que contactan alimentos y metodos para la utilizacion de estas
WO2004093803A3 (en) Photochemotherapeutic compounds for use in treatment of pin1-associated states
MXPA06000318A (es) Pano limpiador y metodos para mejorar la salud de la piel.
PT1161157E (pt) Complemento alimentar e processo de tratamento cosmetico a base de um extracto de uva rico em polifenois
SG155189A1 (en) Novel fenofibrate formulations and related methods of treatment
HK1061516A1 (en) Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
MX2008001597A (es) Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento.
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
WO2004031202A3 (de) Kondensierte palatinose in hydrierter form
MXPA05013625A (es) Combinaciones de agentes vasoprotectores y formulaciones que contienen los mismos.
AU6426901A (en) Oily cosmetics
SI1519709T1 (sl) Nove kozmetične aplikacije polifenolov in njihovih derivatov
BR0005332A (pt) Aroma encapsulado
IT1320166B1 (it) Procedimento di trattamento di frutta e verdura utilizzante tocoferolicome antiossidanti.
WO2004052294A3 (en) Compositions and methods related to lipid:emodin formulations
AU2001277599A1 (en) Essential oil combination and therapeutic uses thereof
AU2003302176A8 (en) Antioxidant for fats, oils and food
SG155219A1 (en) Skin care products, as well as foods and beverages containing 6-o-pufa ascorbic esters
MXPA05005986A (es) Tratamiento superficial para madera y productos de madera.
UA85187C2 (en) 2-aminobenzoyl derivatives
WO2005018564A3 (en) Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage
WO2002011719A3 (en) Lipase inhibitors for the treatment of dyspepsia

Legal Events

Date Code Title Description
FG Grant or registration